Literature DB >> 7513517

The riddle of the mast cell: kit(CD117)-ligand as the missing link?

P Valent1.   

Abstract

Tissue mast cells are multifunctional immune cells and have been implicated in allergic and inflammatory reactions. However, while the role of allergen binding to surface IgE via the high-affinity Fc epsilon receptor on mast cells is well understood, major questions in mast-cell biology remain to be answered. In particular, it is largely unknown which stimuli lead to the differentiation of human mast cells from their precursor cells and how the maturing cells localize (or home) and acquire effector functions within the microvasculature. A potential solution is suggested by Peter Valent in this viewpoint. The emerging concept is that a single tissue hormone, the ligand of the c-kit tyrosine kinase receptor (CD117), provides a key signal in multiple aspects of mast-cell differentiation and function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513517     DOI: 10.1016/0167-5699(94)90153-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  20 in total

1.  High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.

Authors:  Robert Fritsche-Polanz; Marika Fritz; Andrea Huber; Karl Sotlar; Wolfgang R Sperr; Christine Mannhalter; Manuela Födinger; Peter Valent
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

Review 2.  Current approach to cutaneous mastocytosis in childhood.

Authors:  Zeynep Tamay; Deniz Özçeker
Journal:  Turk Pediatri Ars       Date:  2016-09-01

3.  Topical tretinoin increases dermal mast cells, induces epidermal mast cell growth factor (c-kit ligand) and modulates its distribution in hairless mice.

Authors:  L H Kligman; G F Murphy
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

4.  Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.

Authors:  A Juurikivi; C Sandler; K A Lindstedt; P T Kovanen; T Juutilainen; M J Leskinen; T Mäki; K K Eklund
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

Review 5.  Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.

Authors:  M Rossini; R Zanotti; G Orsolini; G Tripi; O Viapiana; L Idolazzi; A Zamò; P Bonadonna; V Kunnathully; S Adami; D Gatti
Journal:  Osteoporos Int       Date:  2016-02-18       Impact factor: 4.507

6.  Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes.

Authors:  H Agis; W Füreder; H C Bankl; M Kundi; W R Sperr; M Willheim; G Boltz-Nitulescu; J H Butterfield; K Kishi; K Lechner; P Valent
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

Review 7.  Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.

Authors:  Peter Valent; Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Wolfgang R Sperr; Michel Arock
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

8.  Stem cell factor potentiates histamine secretion by multiple mechanisms, but does not affect tumour necrosis factor-alpha release from rat mast cells.

Authors:  T J Lin; E Y Bissonnette; A Hirsh; A D Befus
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

9.  Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.

Authors:  Peter Valent
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

10.  The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard.

Authors:  J Tsuruta; K Sugisaki; A M Dannenberg; T Yoshimura; Y Abe; P Mounts
Journal:  Inflammation       Date:  1996-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.